Listen Now
Topics Covered
- Clinical Applications of Circulating Tumor DNA
- Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
- Novel Therapeutics and Therapy Related Toxicity in Triple Negative Breast Cancer
- Questions for Our Panel of Experts
Our Panel of Experts

Kate Lathrop, MD
Associate Professor, Division of Hematology and Oncology, UT Health San Antonio, Breast Medical Oncology, Mays Cancer Center at UT Health San Antonio, Assistant Dean of Undergraduate Research, Long School of Medicine, UT Health San Antonio, Program Director, Medical Oncology and Hematology Fellowship Program, UT Health San Antonio, Program Director, San Antonio Breast Cancer Symposium (SABCS)
Roberto A. Leon-Ferre, MD
Associate Professor of Oncology, Department of Oncology, Co-Chair of the Mayo Clinic TNBC Working Group, Associate Program Director, Advanced Breast Medical Oncology Fellowship Program, Mayo Clinic

Julie G. Fisher, MD
Medical Oncologist, Levine Cancer Institute, Co-Director, Sandra Levine Young Women’s Breast Cancer Program, Associate Hematology/Oncology Fellowship Director, Levine Cancer Institute

Arlene Brothers
Interim Executive Director, Triple Negative Breast Cancer Foundation®

Jennifer LaPietra, MSW
Patient Assistance Program Manager, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on January 06, 2026.
